Chairman:
Per-Olof Gunnesson, (born 1945) has a Business School degree and is currently the vice president, economics and business development at InDex Pharmaceuticals AB and InDex Diagnostics AB. He has almost 40 years experience in biotech/pharmaceutical industry, including the ASTRA group.
|
 |
| Per-Olof Gunnesson |
|
| Professor Thomas Borén, DDS, PhD, (born 1960) is Professor at Umeå university. His scientific interest includes molecular genetics and pathogenesis of Helicobacter pylori. He has published a number of papers in high-ranked journals in this field. He has recieved many prestigeous awards, and his discoveries in the H. pylori field has been noticed both at the international as well as the national level. He is the main inventors on the original H. pylori patent applications. |
 |
Prof. Thomas Borén
|
|
| Associate professor Jacob Odeberg, MD, PhD, M.Sci. Chem. Engineer. (born 1963), is Associate Professor in Molecular Biotechnology at the Royal Institute of Technology and affiliated with the Department of Medicine, Karolinska Institutet. He holds a residency in Hematology at the Karolinska University Hospital, combining clinical work with active research in Molecular Medicine and Medical Biotechnology. He is also one of the inventors and active founders of CytaCoat AB. He is deputy board member of the Kempe Foundations. |
 |
| Ass. prof. Jacob Odeberg |
|
Bo Hammarström (born 1953) Bachelor in Business Administration (SSE) and MSci Forestry. He has a strong background from leading positions in various industry and 20 years experience as a member of the board of directors in Swedish industrial companies. He was Chairman and major shareholder in the life science company SeQuant AB which was acquired by Merck KGaA in 2008. He is a member of the board of directors and also shareholder in several startup companies in life Science and in other industry.
|
 |
Bo Hammarström
|
|
|
|
|
|
|
|
|
